These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25694414)

  • 1. Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion.
    Berti AD; Hutson PR; Schulz LT; Webb AP; Rose WE
    Am J Health Syst Pharm; 2015 Mar; 72(5):390-5. PubMed ID: 25694414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions.
    Leung E; Venkatesan N; Ly SC; Scheetz MH
    Am J Health Syst Pharm; 2013 Jul; 70(13):1163-6. PubMed ID: 23784164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability and Compatibility of Antibiotics in Peritoneal Dialysis Solutions Applied to Automated Peritoneal Dialysis in The Pediatric Population.
    Deslandes G; Grégoire M; Bouquié R; Le Marec A; Allard S; Dailly E; Pineau A; Allain-Launay E; Jolliet P; Roussey G; Navas D
    Perit Dial Int; 2016 11-12; 36(6):676-679. PubMed ID: 27147292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration.
    Katip W
    Am J Health Syst Pharm; 2017 Jul; 74(14):1099-1102. PubMed ID: 28687555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility and stability of aztreonam and vancomycin hydrochloride.
    Trissel LA; Xu QA; Martinez JF
    Am J Health Syst Pharm; 1995 Nov; 52(22):2560-4. PubMed ID: 8590240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
    Singh BN; Dedhiya MG; DiNunzio J; Chan P; Kupiec TC; Trissel LA; Laudano JB
    Am J Health Syst Pharm; 2011 Nov; 68(22):2163-9. PubMed ID: 22058102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
    Chan P; Bishop A; Kupiec TC; Trissel LA; Gole D; Jimidar IM; Vermeersch H
    Am J Health Syst Pharm; 2008 Aug; 65(16):1545-51. PubMed ID: 18693210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions.
    LaPlante KL; Woodmansee S; Mermel LA
    Am J Health Syst Pharm; 2012 Aug; 69(16):1405-9. PubMed ID: 22855107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
    Woloschuk DM; Wermeling JR; Pruemer JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2158-60. PubMed ID: 1781472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administration.
    Thabit AK; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2017 Jan; 74(1):e47-e54. PubMed ID: 28007721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability and compatibility of vancomycin for administration by continuous infusion.
    Raverdy V; Ampe E; Hecq JD; Tulkens PM
    J Antimicrob Chemother; 2013 May; 68(5):1179-82. PubMed ID: 23302579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations.
    O'Donnell JN; Venkatesan N; Manek M; Rhodes NJ; Scheetz MH
    Am J Health Syst Pharm; 2016 Feb; 73(4):241-6. PubMed ID: 26843502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam.
    Wade J; Cooper M; Ragan R
    Hosp Pharm; 2015 May; 50(5):376-9. PubMed ID: 26405323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of cefepime in icodextrin peritoneal dialysis solution.
    Elwell RJ; Volino LR; Frye RF
    Ann Pharmacother; 2004 Dec; 38(12):2041-4. PubMed ID: 15494381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF; Simmons M
    J Am Pharm Assoc (Wash); 1999; 39(2):141-5. PubMed ID: 10079649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?
    Kufel WD; Miller CD; Johnson PR; Reid K; Zahra JJ; Seabury RW
    Hosp Pharm; 2017 Feb; 52(2):132-137. PubMed ID: 28321140
    [No Abstract]   [Full Text] [Related]  

  • 18. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs.
    Cochran BG; Sowinski KM; Fausel C; Overholser BR
    Am J Health Syst Pharm; 2007 Jul; 64(13):1410-4. PubMed ID: 17592007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions.
    Wilder AG; Foushee JA; Fox LM; Navalle J; Wright AM; Greer MA
    Int J Pharm Compd; 2020; 24(3):238-241. PubMed ID: 32401743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.